Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 19, 2006Journal of Clinical Oncology

OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study

View Full Paper
Ask AI
Bookmark
Share

Authors

CTChristophe TournigandInsermACAndrés CervantesRoche (Switzerland)AFArié FigerOntario Institute for Cancer Research

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tournigand et al. (2006) studied this question.

synapsesocial.com/papers/69d7cd4e319e71454dbedab7https://doi.org/10.1200/jco.2005.03.0106
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer2000 · 3,834 citations
  2. 2Phase III Randomized Trial of Docetaxel Plus Cisplatin Versus Vindesine Plus Cisplatin in Patients With Stage IV Non-Small-Cell Lung Cancer: The Japanese Taxotere Lung Cancer Study Group2004 · 232 citations
  3. 3Regression Models and Life-Tables1972 · 39,949 citations
  4. 4Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.1997 · 907 citations